These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6686025)

  • 1. [Production and properties of a new chemically modified i.v. immunoglobulin: Polyglobin].
    Spilles C
    Beitr Infusionther Klin Ernahr; 1983; 11():26-33. PubMed ID: 6686025
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemical modification with beta-propiolactone as a general concept for the production of intravenously tolerable immunoglobulin preparations].
    Stephan W
    Beitr Infusionther Klin Ernahr; 1983; 11():20-5. PubMed ID: 6686024
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of in vitro behaviour and in vivo efficacy of two 7S-immunoglobulin preparations for intravenous use.
    Stephan W; Dichtelmüller H
    Arzneimittelforschung; 1983; 33(11):1538-40. PubMed ID: 6686449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new intact immunoglobulin for intravenous use stabilized by chemically modified gelatin derivatives.
    Tomono T; Ikeda K; Suzuki T
    Vox Sang; 1986; 51(2):81-6. PubMed ID: 3776140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function relationships of immunoglobulin G.
    Painter RH; Dorrington KJ
    Prog Clin Biol Res; 1980; 43():121-32. PubMed ID: 6775321
    [No Abstract]   [Full Text] [Related]  

  • 6. [Structure and function of immunoglobulins].
    Seiler FR
    Beitr Infusionther Klin Ernahr; 1982; 9():1-15. PubMed ID: 6816212
    [No Abstract]   [Full Text] [Related]  

  • 7. Radioimmunoassay of human urinary immunoglobulin G.
    Saravis CA; Wool MS; Selenkow HA
    Vox Sang; 1967 Oct; 13(4):349-53. PubMed ID: 5633771
    [No Abstract]   [Full Text] [Related]  

  • 8. Human coagluation factor V purification and thrombin-catalyzed activation.
    Dahlbäck B
    J Clin Invest; 1980 Sep; 66(3):583-91. PubMed ID: 7400329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new immune serum globulin preparation for intravenous administration (author's transl)].
    Mozen MM; Schroeder DD; Cabasso VJ
    Arzneimittelforschung; 1980; 30(9):1484-6. PubMed ID: 7193013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloantibodies to factor IX in Haemophilia B characterized by crossed immunoelectrophoresis and enzyme-conjugated antisera to human immunoglobulins.
    Orstavik KH
    Br J Haematol; 1981 May; 48(1):15-23. PubMed ID: 6788066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The first component of complement. I. Purification and properties of native C1.
    Medicus RG; Chapuis RM
    J Immunol; 1980 Jul; 125(1):390-5. PubMed ID: 7381205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possibility of decreasing the anticomplement activity of human immunoglobulin preparations via chemical modification].
    Potemkina EE; Galkina LV; Khrometskaia TM; Krylova EE; Mamaeva TA
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jun; (6):54-7. PubMed ID: 3630482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirements and characteristics of various immunoglobulin preparations for intravenous application.
    Guencheva G
    Z Gesamte Hyg; 1984 Jan; 30(1):21-3. PubMed ID: 6711042
    [No Abstract]   [Full Text] [Related]  

  • 15. The estimation of Stokes radius for secretory immunoglobulin A, using thin-layer chromatography followed by crossed immunoelectrophoresis.
    Chandy KG; Stockley RA; Burnett D
    Hoppe Seylers Z Physiol Chem; 1980 Dec; 361(12):1855-7. PubMed ID: 7461611
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular structure alteration of IgG increased anticomplementary activity of intravenous immunoglobulin.
    Zang XX; Sun Y; Shen F; Wang D; Zhou L; Wang J; Kung E
    Zhongguo Yao Li Xue Bao; 1995 Sep; 16(5):415-9. PubMed ID: 8701757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The cause of the secondary reaction in the intravenous use of administered immunoglobulin].
    Geursen RG; Kroh U; Krump W; Scharfe B
    Beitr Infusionther Klin Ernahr; 1982; 9():95-114. PubMed ID: 6756385
    [No Abstract]   [Full Text] [Related]  

  • 18. Complement activation contributes to leukocyte recruitment and neuropathic pain following peripheral nerve injury in rats.
    Li M; Peake PW; Charlesworth JA; Tracey DJ; Moalem-Taylor G
    Eur J Neurosci; 2007 Dec; 26(12):3486-500. PubMed ID: 18052971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the alternative complement pathway: recognition of surface structures on activators by bound C3b.
    Pangburn MK; Morrison DC; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1980 Feb; 124(2):977-82. PubMed ID: 7356723
    [No Abstract]   [Full Text] [Related]  

  • 20. [The crucial component of the complement pathway-C3].
    Zao XZ
    Sheng Li Ke Xue Jin Zhan; 1982 Oct; 13(4):292-9. PubMed ID: 7167791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.